Optimvia
PrivateLast Round
Seed
Apr 8, 2026
Total Funding Raised
$523,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Optimvia is a biopharmaceutical company that has developed a biosynthetic manufacturing process designed for engineering enzymes and their cofactors to synthesize complex therapeutic molecules like heparin.
Sector
AI, Data & Cloud Infrastructure
Verticals
Cloud Infrastructure, DevOps & Containers, Workflow Automation, Platform-as-a-Service
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Optimvia Comparables
Compare Optimvia with similar companies based on industry and business-model similarity.
Optimvia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 8, 2026 | ||||
| Seed | Aug 29, 2023 |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 142% MoM.
- Apr 8, 2026
$75K Seed Round raised.
Optimvia Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Optimvia's valuation, stock price, and market status.